Evidence for the effects of yogurt on gut health and obesity

Critical Reviews in Food Science and Nutrition

Volumn 57, Issue 8, 2017, Pages 1569-1583

  Pei, Ruisong ^a,b   Martin, Derek A ^a,b   DiMarco, Diana M ^a   Bolling, Bradley W ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

bioactives; chronic disease; inflammation; intestine; obesity; Yogurt

Indexed keywords

DAIRY PRODUCTS; HEALTH; NUTRITION; PATHOLOGY;

BIOACTIVES; CHRONIC DISEASE; INFLAMMATION; INTESTINE; OBESITY; YOGURT;

DISEASES;

IMMUNOGLOBULIN A; PROBIOTIC AGENT; YOGHURT;

ADIPOSE TISSUE; ANIMAL; APPETITE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COMPLICATION; CYTOLOGY; DIABETES MELLITUS, TYPE 2; DIET; DISEASE MODEL; GASTROINTESTINAL TRACT; HUMAN; INFLAMMATION; INTESTINE FLORA; INTESTINE MUCOSA; META ANALYSIS (TOPIC); METABOLISM; MICROBIOLOGY; NEOPLASMS; NUTRITIONAL VALUE; OBESITY; RISK FACTOR;

ADIPOSE TISSUE; ANIMALS; APPETITE; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DIET; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; IMMUNOGLOBULIN A; INFLAMMATION; INTESTINAL MUCOSA; META-ANALYSIS AS TOPIC; NEOPLASMS; NUTRITIVE VALUE; OBESITY; PROBIOTICS; RISK FACTORS; YOGURT;

EID: 84956681148     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2014.883356     Document Type: Article

References (224)

1. Adolfsson, O., Meydani, S. N., and Russell, R. M., (2004). Yogurt and gut function. Am. J. Clin. Nutr. 80:245–256.
2. Agostini, S., Goubern, M., Tondereau, V., Salvador-Cartier, C., Bezirard, V., Lévèque, M., et al. (2012). A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol. Motil. 24:376–e172.
3. Al-Sadi, R., Boivin, M., and Ma, T., (2009). Mechanism of cytokine modulation of epithelial tight junction barrier. Front. Biosci. 14:2765–2778.
4. Al-Sadi, R. M., and Ma, T. Y., (2007). IL-1β causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 178:4641–4649.
5. Amar, J., Burcelin, R., Ruidavets, J. B., Cani, P. D., Fauvel, J., Alessi, M. C., et al. (2008). Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 87:1219–1223.
6. Anderson, J. W., and Gilliland, S. E., (1999). Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J. Am. Coll. Nutr. 18:43–50.
7. Andreasen, A. S., Larsen, N., Pedersen-Skovsgaard, T., Berg, R. M. G., Mller, K., Svendsen, K. D., et al. (2010). Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br. J. Nutr. 104:1831–1838.
8. Aneja, R. P., and Murthi, T. N., (1990). Conjugated linoleic acid contents of Indian curds and ghee. Indian J. Dairy Sci. 43:231–238.
9. Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., et al. (1997). A clinical trial of the effects of dietary patterns on blood pressure. N. Engl. J. Med. 336:1117–1124.
10. Bäckhed, F., (2009). Changes in intestinal microflora in obesity:Cause or consequence? J. Pediatr. Gastroenterol. Nutr. 48:S56–S57.
11. Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Gou, Y. K., Nagy, A., et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 101:15718–15723.
12. Bäckhed F., Manchester, J. K., Semenkovich, C. F., and Gordon, J. I., (2007). Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U. S. A. 104:979–984.
13. Bashan, N., Dorfman, K., Tarnovscki, T., Harman-Boehm, I., Liberty, I. F., Her, M. B., et al. (2007). Mitogen-activated protein kinases, inhibitory-κB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology 148:2955–2962.
14. Bluher, M., Engeli, S., Kloting, N., Berndt, J., Fasshauer, M., Batkai, S., et al. (2006). Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55:3053–3060.
15. Boschi-Pinto, C., Velebit, L., and Shibuya, K., (2008). Estimating child mortality due to diarrhoea in developing countries. Bull. World Health Organ. 86:710–717.
16. Brake, D. K., Smith, E. O. B., Mersmann, H., Smith, C. W., and Robker, R. L., (2006). ICAM-1 expression in adipose tissue:Effects of diet-induced obesity in mice. Am. J. Physiol. Cell Physiol. 291:C1232–C1239.
17. Brandtzaeg, P., Baekkevold, E. S., Farstad, I. N., Jahnsen, F. L., Johansen, F. E., Nilsen, E. M., et al. (1999). Regional specialization in the mucosal immune system:What happens in the microcompartments? Immunol. Today 20:141–151.
18. Breslaw, E. S., and Kleyn, D. H., (1973). In vitro digestibility of protein in yogurt at various stages of processing. J. Food Sci. 38:1016–1021.
19. Bruewer, M., Utech, M., Ivanov, A. I., Hopkins, A. M., Parkos, C. A., and Nusrat, A., (2005). Interferon-γ induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J. 19:923–933.
20. Brun, P., Castagliuolo, I., Di Leo, V., Buda, A., Pinzani, M., Palù, G., et al. (2007). Increased intestinal permeability in obese mice:New evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 292:G518–G525.
21. Buttriss, J., (1997). Nutritional properties of fermented milk products. Int. J. Dairy Technol. 50:21–27.
22. Caballero-Franco, C., Keller, K., De Simone, C., and Chadee, K., (2007). The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292:G315–G322.
23. Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., et al. (2005). Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat. Med. 11:183–190.
24. Calle, E. E., Rodriguez, C., Walker-Thurmond, K., and Thun, M. J., (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. N. Engl. J. Med. 348:1625–1638.
25. Cameron, H. L., and Perdue, M. H., (2005). Stress impairs murine intestinal barrier function:Improvement by glucagon-like peptide-2. J. Pharmacol. Exp. Ther. 314:214–220.
26. Cameron, H. L., Yang, P. C., and Perdue, M. H., (2003). Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy. Am. J. Physiol. Gastrointest. Liver Physiol. 284:G905–G912.
27. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772.
28. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., et al. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470–1481.
29. Chapelot, D., and Payen, F., (2010). Comparison of the effects of a liquid yogurt and chocolate bars on satiety:A multidimensional approach. Br. J. Nutr. 103:760–767.
30. Chaves, S., Perdigon, G., and De Moreno De Leblanc, A., (2011). Yoghurt consumption regulates the immune cells implicated in acute intestinal inflammation and prevents the recurrence of the inflammatory process in a mouse model. J. Food Prot. 74:801–811.
31. Chen, R. M., Wu, J. J., Lee, S. C., Huang, A. H., and Wu, H. M., (1999). Increase of intestinal Bifidobacterium and suppression of coliform bacteria with short-term yogurt ingestion. J. Dairy Sci. 82:2308–2314.
32. Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo Jr, J. L., et al. (2003). The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure:The JNC 7 report. JAMA. 289:2560–2572.
33. Claes, I. J. J., De Keersmaecker, S. C. J., Vanderleyden, J., and Lebeer, S., (2011). Lessons from probiotic-host interaction studies in murine models of experimental colitis. Mol. Nutr. Food Res. 55:1441–1453.
34. Clark, E., Hoare, C., Tanianis-Hughes, J., Carlson, G. L., and Warhurst, G., (2005). Interferon γ induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 128:1258–1267.
35. Cluny, N. L., Reimer, R. A., and Sharkey, K. A., (2012). Cannabinoid signalling regulates inflammation and energy balance:The importance of the brain-gut axis. Brain Behav. Immun. 26:691–698.
36. Cohen, A. B., Lee, D., Long, M. D., Kappelman, M. D., Martin, C. F., Sandler, R. S., et al. (2013). Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig. Dis. Sci. 58:1322–1328.
37. Corthésy, B., (2007). Roundtrip ticket for secretory IgA:Role in mucosal homeostasis? J. Immunol. 178:27–32.
38. Côté, M., Matias, I., Lemieux, I., Petrosino, S., Alméras, N., Després, J. P., et al. (2007). Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int. J. Obes (Lond). 31:692–699.
39. Creely, S. J., McTernan, P. G., Kusminski, C. M., Fisher, F. M., Da Silva, N. F., Khanolkar, M., et al. (2007). Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292:E740–E747.
40. Crittenden, R. G., Martinez, N. R., and Playne, M. J., (2003). Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int. J. Food Microbiol. 80:217–222.
41. Curat, C. A., Wegner, V., Sengenès, C., Miranville, A., Tonus, C., Busse, R., et al. (2006). Macrophages in human visceral adipose tissue:Increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49:744–747.
42. De Paula, R. B., Da Silva, A. A., and Hall, J. E., (2004). Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration. Hypertension 43:41–47.
43. De Simone, C., Bianchi Salvadori, B., and Negri, R., (1986). The adjuvant effect of yogurt on production of gamma-interferon by Con A-stimulated human peripheral blood lymphocytes. Nutr. Rep. Int. 33:419–433.
44. De Souza, C. T., Araujo, E. P., Bordin, S., Ashimine, R., Zollner, R. L., Boschero, A. C., et al. (2005). Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146:4192–4199.
45. Del Campo, R., Bravo, D., Cantón, R., Ruiz-Garbajosa, P., García-Albiach, R., Montesi-Libois, A., et al. (2005). Scarce evidence of yogurt lactic acid bacteria in human feces after daily yogurt consumption by healthy volunteers. Appl. Environ. Microbiol. 71:547–549.
46. Desobry-Banon, S., Vetier, N., and Hardy, J., (1999). Health benefits of yogurt consumption. A review. Int. J. Food Prop. 2:1–12.
47. Dharmani, P., Srivastava, V., Kissoon-Singh, V., and Chadee, K., (2009). Role of intestinal mucins in innate host defense mechanisms against pathogens. J. Innate Immun. 1:123–135.
48. Dougkas, A., Minihane, A. M., Givens, D. I., Reynolds, C. K., and Yaqoob, P., (2012). Differential effects of dairy snacks on appetite, but not overall energy intake. Br. J. Nutr. 108:2274–2285.
49. Douglas, S. M., Ortinau, L. C., Hoertel, H. A., and Leidy, H. J., (2013). Low, moderate, or high protein yogurt snacks on appetite control and subsequent eating in healthy women. Appetite 60:117–122.
50. Dunlap, B. S., Yu, H., and Elitsur, Y., (2009). The probiotic content of commercial yogurts in West Virginia. Clin. Pediatr. (Phila). 48:522–527.
51. Ebringer, L., Ferenčík, M., and Krajčovič, J., (2008). Beneficial health effects of milk and fermented dairy products - Review. Folia Microbiol. 53:378–394.
52. Egan, B. M., Zhao, Y., and Axon, R. N., (2010). US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 303:2043–2050.
53. Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., et al. (2007). Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356–2370.
54. Elli, M., Callegari, M. L., Ferrari, S., Bessi, E., Cattivelli, D., Soldi, S., et al. (2006). Survival of yogurt bacteria in the human gut. Appl. Environ. Microbiol. 72:5113–5117.
55. Erridge, C., Attina, T., Spickett, C. M., and Webb, D. J., (2007). A high-fat meal induces low-grade endotoxemia:Evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86:1286–1292.
56. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., et al. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U. S. A. 110:9066–9071.
57. Fabian, E., and Elmadfa, I., (2006). Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Ann. Nutr. Metab. 50:387–393.
58. Flegal, K. M., Carroll, M. D., Ogden, C. L., and Curtin, L. R., (2010). Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 303:235–241.
59. Gaudichon, C., Roos, N., Mahe, S., Sick, H., Bouley, C., and Tome, D., (1994). Gastric emptying regulates the kinetics of nitrogen absorption from 15N- labeled milk and 15N-labeled yogurt in miniature pigs. J. Nutr. 124:1970–1977.
60. German, J. B., Gibson, R. A., Krauss, R. M., Nestel, P., Lamarche, B., Van Staveren, W. A., et al. (2009). A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur. J. Nutr. 48:191–203.
61. Ghanim, H., Sia, C. L., Upadhyay, M., Korzeniewski, K., Viswanathan, P., Abuaysheh, S., et al. (2010). Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression. Am. J. Clin. Nutr. 91:940–949.
62. Gill, H. S., Rutherfurd, K. J., Prasad, J., and Gopal, P. K., (2000). Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr. 83:167–176.
63. Gilliland, S. E., and Speck, M. L., (1977). Instability of Lactobacillus acidophilus in Yogurt. J. Dairy Sci. 60:1394–1398.
64. Gobbato, N., Rachid, M., and Perdigón, G., (2008). Anti-inflammatory effect of yoghurt in an experimental inflammatory bowel disease in mouse. J. Dairy Res. 75:497–504.
65. Gonzalez-Quintela, A., Alende, R., Gude, F., Campos, J., Rey, J., Meijide, L. M., et al. (2008). Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol 151:42–50.
66. Goodfriend, T. L., and Calhoun, D. A., (2004). Resistant Hypertension, Obesity, Sleep Apnea, and Aldosterone:Theory and Therapy. Hypertension 43:518–524.
67. Gorbach, S. L., (1990). Lactic acid bacteria and human health. Ann. Med. 22:37–41.
68. Gregor, M. F., and Hotamisligil, G. S., (2011). Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29:415–445.
69. Grundy, S. M., (2007). Metabolic syndrome:A multiplex cardiovascular risk factor. J. Clin. Endocrinol. Metab. 92:399–404.
70. Guarner, F., Perdigon, G., Corthier, G., Salminen, S., Koletzko, B., and Morelli, L., (2005). Should yoghurt cultures be considered probiotic? Br. J. Nutr. 93:783–786.
71. Gueguen, L., and Pointillart, A., (2000). The bioavailability of dietary calcium. J. Am. Coll. Nutr. 19:119S–136S.
72. Gummesson, A., Carlsson, L. M. S., Storlien, L. H., Bäckhed, F., Lundin, P., Löfgren, L., et al. (2011). Intestinal permeability is associated with visceral adiposity in healthy women. Obesity 19:2280–2282.
73. Halpern, G. M., Vruwink, K. G., Van De Water, J., Keen, C. L., and Gershwin, M. E., (1991). Influence of long-term yoghurt consumption in young adults. Int. J. Immunother. 7:205–210.
74. Hartsock, A., and Nelson, W. J., (2008). Adherens and tight junctions:Structure, function and connections to the actin cytoskeleton. Biochim. Biophys. Acta 1778:660–669.
75. Haslam, D. W., and James, W. P. T., (2005). Obesity Lancet 366:1197–1209.
76. Hedin, C., Whelan, K., and Lindsay, J. O., (2007). Evidence for the use of probiotics and prebiotics in inflammatory bowel disease:A review of clinical trials. Proc. Nutr. Soc. 66:307–315.
77. Herder, C., Schneitler, S., Rathmann, W., Haastert, B., Schneitler, H., Winkler, H., et al. (2007). Low-grade inflammation, obesity, and insulin resistance in adolescents. J. Clin. Endocrinol. Metab. 92:4569–4574.
78. Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., et al. (2002). A central, role for JNK in obesity and insulin resistance. Nature 420:333–336.
79. Hodin, C. M., Verdam, F. J., Grootjans, J., Rensen, S. S., Verheyen, F. K., Dejong, C. H. C., et al. (2011). Reduced Paneth cell antimicrobial protein levels correlate with activation of the unfolded protein response in the gut of obese individuals. J. Pathol. 225:276–284.
80. Holes-Lewis, K. A., Malcolm, R., and O'Neil, P. M., (2013). Pharmacotherapy of obesity:Clinical treatments and considerations. Am. J. Med. Sci. 345:284–288.
81. Hossain, P., Kawar, B., and El Nahas, M., (2007). Obesity and diabetes in the developing world - A growing challenge. N. Engl. J. Med. 356:213–215.
82. Hotamisligil, G. S., (2006). Inflammation and metabolic disorders. Nature 444:860–867.
83. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., and Spiegelman, B. M., (1995). Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95:2409–2415.
84. Howe, K. L., Reardon, C., Wang, A., Nazli, A., and McKay, D. M., (2005). Transforming growth factor-β regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. Am. J. Pathol. 167:1587–1597.
85. Huth, P. J., and Park, K. M., (2012). Influence of dairy product and milk fat consumption on cardiovascular disease risk:a review of the evidence. Adv. Nutr. 3:266–285.
86. Irvine, S. L., Hummelen, R., Hekmat, S., W. N. Looman, C., Habbema, J. D. F., and Reid, G., (2010). Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J. Clin. Gastroenterol. 44:e201–e205.
87. Isolauri, E., Kaila, M., Arvola, T., Majamaa, H., Rantala, I., Virtanen, E., et al. (1993). Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr. Res. 33:548–553.
88. Jijon, H., Backer, J., Diaz, H., Yeung, H., Thiel, D., McKaigney, C., et al. (2004). DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126:1358–1373.
89. Jonkers, D., Penders, J., Masclee, A., and Pierik, M., (2012). Probiotics in the management of inflammatory bowel disease:A systematic review of intervention studies in adult patients. Drugs 72:803–823.
90. Jouet, P., Coffin, B., and Sabate, J. M., (2011). Small intestinal bacterial overgrowth in patients with morbid obesity. Dig. Dis. Sci. 56:615–616.
91. Kabeerdoss, J., Shobana Devi, R., Regina Mary, R., Prabhavathi, D., Vidya, R., Mechenro, J., et al. (2011). Effect of yoghurt containing Bifidobacterium lactis Bb12® on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers. Nutr. J. 10:138.
92. Kahn, S. E., Hull, R. L., and Utzschneider, K. M., (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846.
93. Kale-Pradhan, P. B., Jassal, H. K., and Wilhelm, S. M., (2010). Role of Lactobacillus in the prevention of antibiotic-associated diarrhea:A meta-analysis. Pharmacotherapy 30:119–126.
94. Kastarinen, M. J., Nissinen, A. M., Vartiainen, E. A., Jousilahti, P. J., Korhonen, H. J., Puska, P. M., et al. (2000). Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997. J. Hypertens. 18:255–262.
95. Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y., Sugitani, M., Imaoka, A., et al. (2004). Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment. Pharmacol. Ther. 20:1133–1141.
96. Kemna, E., Pickkers, P., Nemeth, E., Van Der Hoeven, H., and Swinkels, D., (2005). Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106:1864–1866.
97. Kern, P. A., Ranganathan, S., Li, C., Wood, L., and Ranganathan, G., (2001). Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 280:E745–E751.
98. Kießling, G., Schneider, J., and Jahreis, G., (2002). Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur. J. Clin. Nutr. 56:843–849.
99. Kim, C. S., Park, H. S., Kawada, T., Kim, J. H., Lim, D., Hubbard, N. E., et al. (2006). Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int. J. Obes (Lond). 30:1347–1355.
100. Kim, F., Pham, M., Luttrell, I., Bannerman, D. D., Tupper, J., Thaler, J., et al. (2007). Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100:1589–1596.
101. Kim, Y. S., and Ho, S. B., (2010). Intestinal goblet cells and mucins in health and disease:Recent insights and progress. Curr. Gastroenterol. Rep. 12:319–330.
102. Kinugasa, T., Sakaguchi, T., Gu, X., and Reinecker, H., (2000). Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118:1001–1011.
103. Kolars, J. C., Levitt, M. D., Aouji, M., and Savaiano, D. A., (1984). Yogurt - an autodigesting source of lactose. N. Engl. J. Med. 310:1–3.
104. Labonté, M. E., Couture, P., Richard, C., Desroches, S., and Lamarche, B., (2013). Impact of dairy products on biomarkers of inflammation:A systematic review of randomized controlled nutritional intervention studies in overweight and obese adults. Am. J. Clin. Nutr. 97:706–717.
105. Larsson, S. C., Andersson, S. O., Johansson, J. E., and Wolk, A., (2008). Cultured milk, yogurt, and dairy intake in relation to bladder cancer risk in a prospective study of Swedish women and men. Am. J. Clin. Nutr. 88:1083–1087.
106. Larsson, S. C., and Wolk, A., (2007). Obesity and colon and rectal cancer risk:A meta-analysis of prospective studies. Am. J. Clin. Nutr. 86:556–565.
107. Laugerette, F., Vors, C., Géloën, A., Chauvin, M. A., Soulage, C., Lambert-Porcheron, S., et al. (2011). Emulsified lipids increase endotoxemia:Possible role in early postprandial low-grade inflammation. J. Nutr. Biochem. 22:53–59.
108. Lavie, C. J., Milani, R. V., and Ventura, H. O., (2009). Obesity and cardiovascular disease. Risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 53:1925–1932.
109. Leal, E. C., Martins, J., Voabil, P., Liberal, J., Chiavaroli, C., Bauer, J., et al. (2010). Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes 59:2637–2645.
110. Lewington, S., Clarke, R., Qizilbash, N., Peto, R., and Collins, R., (2002). Age-specific relevance of usual blood pressure to vascular mortality:A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913.
111. Ley, R. E., Turnbaugh, P. J., Klein, S., and Gordon, J. I., (2006). Microbial ecology:Human gut microbes associated with obesity. Nature 444:1022–1023.
112. Li, Q., Zhang, Q., Wang, M., Zhao, S., Ma, J., Luo, N., et al. (2008). Interferon-γ and tumor necrosis factor-α disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin. Immunol. 126:67–80.
113. Link-Amster, H., Rochat, F., Saudan, K. Y., Mignot, O., and Aeschlimann, J. M., (1994). Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol. Med. Microbiol. 10:55–63.
114. Lomer, M. C. E., Parkes, G. C., and Sanderson, J. D., (2008). Review article:Lactose intolerance in clinical practice - Myths and realities. Aliment. Pharmacol. Ther. 27:93–103.
115. Lorea Baroja, M., Kirjavainen, P. V., Hekmat, S., and Reid, G., (2007). Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin. Exp. Immunol. 149:470–479.
116. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128.
117. Mack, D. R., Michail, S., Wei, S., McDougall, L., and Hollingsworth, M. A., (1999). Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 276:G941–G950.
118. Macpherson, A. J., and Uhr, T., (2004). Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303:1662–1665.
119. Madsen, K. L., Lewis, S. A., Tavernini, M. M., Hibbard, J., and Fedorak, R. N., (1997). Interleukin 10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology 113:151–159.
120. Manco, M., Putignani, L., and Bottazzo, G. F., (2010). Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr. Rev. 31:817–844.
121. Mankertz, J., Tavalali, S., Schmitz, H., Mankertz, A., Riecken, E. O., Fromm, M., et al. (2000). Expression from the human occludin promoter is affected by tumor necrosis factor α and interferon γ. J. Cell Sci. 113:2085–2090.
122. Marconi, E., Messia, M. C., Amine, A., Moscone, D., Vernazza, F., Stocchi, F., et al. (2004). Heat-treated milk differentiation by a sensitive lactulose assay. Food Chem. 84:447–450.
123. Margolis, K. L., Wei, F., de Boer, I. H., Howard, B. V., Liu, S., Manson, J. E., et al. (2011). A diet high in low-fat dairy products lowers diabetes risk in postmenopausal women. J. Nutr. 141:1969–1974.
124. Maroof, H., Hassan, Z. M., Mobarez, A. M., and Mohamadabadi, M. A., (2012). Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J. Clin. Immunol. 32:1353–1359.
125. Martínez-Maqueda, D., Miralles, B., De Pascual-Teresa, S., Reverón, I., Muñoz, R., and Recio, I., (2012). Food-derived peptides stimulate mucin secretion and gene expression in intestinal cells. J. Agric. Food. Chem. 60:8600–8605.
126. Martini, M. C., Lerebours, E. C., Lin, W. J., Harlander, S. K., Berrada, N. M., Antoine, J. M., et al. (1991). Strains and species of lactic acid bacteria in fermented milks (yogurts):Effect on in vivo lactose digestion. Am. J. Clin. Nutr. 54:1041–1046.
127. Massiéra, F., Bloch-Faure, M., Ceiler, D., Murakami, K., Fukamizu, A., Gasc, J. M., et al. (2001). Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 15:2727–2729.
128. Mater, D. D. G., Bretigny, L., Firmesse, O., Flores, M. J., Mogenet, A., Bresson, J. L., et al. (2005). Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt. FEMS Microbiol. Lett. 250:185–187.
129. Mathieu, P., Lemieux, I., and Després, J. P., (2010). Obesity, inflammation, and cardiovascular risk. Clin. Pharmacol. Ther. 87:407–416.
130. Matsumoto, M., Aranami, A., Ishige, A., Watanabe, K., and Benno, Y., (2007). LKM512 yogurt consumption improves the intestinal environment and induces the T-helper type 1 cytokine in adult patients with intractable atopic dermatitis. Clin. Exp. Allergy 37:358–370.
131. Matsumoto, M., Ohishi, H., and Benno, Y., (2001). Impact of LKM512 yogurt on improvement of intestinal environment of the elderly. FEMS Immunol. Med. Microbiol. 31:181–186.
132. Mauras, N., DelGiorno, C., Kollman, C., Bird, K., Morgan, M., Sweeten, S., et al. (2010). Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J. Clin. Endocrinol. Metab. 95:1060–1068.
133. McNulty, N. P., Yatsunenko, T., Hsiao, A., Faith, J. J., Muegge, B. D., Goodman, A. L., et al. (2011). The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 3:106ra106.
134. Miele, E., Pascarella, F., Giannetti, E., Quaglietta, L., Baldassano, R. N., and Staiano, A., (2009). Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am. J. Gastroenterol. 104:437–443.
135. Moghaddam, A. A., Woodward, M., and Huxley, R., (2007). Obesity and risk of colorectal cancer:A meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol. Biomarkers Prev. 16:2533–2547.
136. Morikawa, K., Kondo, I., Kanamaru, Y., and Nagaoka, S., (2007). A novel regulatory pathway for cholesterol degradation via lactostatin. Biochem. Biophys. Res. Commun. 352:697–702.
137. Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. M., et al. (2010). The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 6.
138. Muoio, D. M., and Newgard, C. B., (2008). Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9:193–205.
139. Nakamura, T., Mizutani, J., Sasaki, K., Yamamoto, N., and Takazawa, K., (2009). Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index:A preliminary study. J. Med. Food 12:1221–1226.
140. National-Yogurt-Association (2008). Live and Active Culture Yogurt Seal Program. McLean, VA.
141. Nicklas, T. A., Qu, H., Hughes, S. O., He, M., Wagner, S. E., Foushee, H. R., et al. (2011). Self-perceived lactose intolerance results in lower intakes of calcium and dairy foods and is associated with hypertension and diabetes in adults. Am. J. Clin. Nutr. 94:191–198.
142. O'Hara, A. M., and Shanahan, F., (2006). The gut flora as a forgotten organ. EMBO Rep. 7:688–693.
143. O'Sullivan, M. G., Thornton, G., O'Sullivan, G. C., and Collins, J. K., (1992). Probiotic bacteria:myth or reality? Trends Food Sci. Tech. 3:309–314.
144. Ohmura, K., Ishimori, N., Ohmura, Y., Tokuhara, S., Nozawa, A., Horii, S., et al. (2010). Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler. Thromb. Vasc. Biol. 30:193–199.
145. Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., et al. (2001). The extra domain A of fibronectin activates toll-like receptor 4. J. Biol. Chem. 276:10229–10233.
146. Ortakci, F., and Sert, S., (2012). Stability of free and encapsulated Lactobacillus acidophilus ATCC 4356 in yogurt and in an artificial human gastric digestion system. J. Dairy Sci. 95:6918–6925.
147. Oshima, T., Laroux, F. S., Coe, L. L., Morise, Z., Kawachi, S., Bauer, P., et al. (2001). Interferon-γ and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc. Res. 61:130–143.
148. Pala, V., Sieri, S., Berrino, F., Vineis, P., Sacerdote, C., Palli, D., et al. (2011). Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort. Int. J. Cancer 129:2712–2719.
149. Panagiotakos, D. B., Pitsavos, C., Yannakoulia, M., Chrysohoou, C., and Stefanadis, C., (2005). The implication of obesity and central fat on markers of chronic inflammation:The ATTICA study. Atherosclerosis 183:308–315.
150. Park, B. S., Song, D. H., Kim, H. M., Choi, B. S., Lee, H., and Lee, J. O., (2009). The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191–1195.
151. Park, Y., Albright, K. J., Liu, W., Storkson, J. M., Cook, M. E., and Pariza, M. W., (1997). Effect of conjugated linoleic acid on body composition in mice. Lipids 32:853–858.
152. Parvez, S., Malik, K. A., Ah Kang, S., and Kim, H. Y., (2006). Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol. 100:1171–1185.
153. Peeters, A., Barendregt, J. J., Willekens, F., Mackenbach, J. P., Al Mamun, A., Bonneux, L., et al. (2003). Obesity in adulthood and its consequences for life expectancy:A life-table analysis. Ann. Intern. Med. 138:24–32.
154. Perdigon, G., Alvarez, S., Rachid, M., Agüero, G., and Gobbato, N., (1995). Immune system stimulation by probiotics. J. Dairy Sci. 78:1597–1606.
155. Pineiro, M., and Embarek, B., (2002). Guidelines for the Evaluation of Probiotics in Food. LondonOntario, Canada, FAO/WHO.
156. Porter, E. M., Bevins, C. L., Ghosh, D., and Ganz, T., (2002). The multifaceted Paneth cell. Cell Mol. Life Sci. 59:156–170.
157. Pugin, J., Heumann, D., Tomaszi, A., Kravchenko, V. V., Akamatsu, Y., Nishijima, M., et al. (1994). CD14 is a pattern recognition receptor. Immunity 1:509–516.
158. Puri, P., Rattan, A., Bijlani, R. L., Mahapatra, S. C., and Nath, I., (1996). Splenic and intestinal lymphocyte proliferation response in mice fed milk or yogurt and challenged with Salmonella typhimurium. Int. J. Food Sci. Nutr. 47:391–398.
159. Raetz, C. R. H., and Whitfield, C., (2002). Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635–700.
160. Rahmouni, K., Correia, M. L. G., Haynes, W. G., and Mark, A. L., (2005). Obesity-associated hypertension:New insights into mechanisms. Hypertension 45:9–14.
161. Rallabhandi, P., Bell, J., Boukhvalova, M. S., Medvedev, A., Lorenz, E., Arditi, M., et al. (2006). Analysis of TLR4 polymorphic variants:New insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J. Immunol. 177:322–332.
162. Ralston, R. A., Lee, J. H., Truby, H., Palermo, C. E., and Walker, K. Z., (2012). A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J. Hum. Hypertens. 26:3–13.
163. Recker, R. R., Bammi, A., Barger-Lux, M., and Heaney, R. P., (1988). Calcium absorbability from milk products, an imitation milk and calcium carbonate. Am. J. Clin. Nutr. 47:93–95.
164. Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., and Bull, D., (2007). Cancer incidence and mortality in relation to body mass index in the Million Women Study:Cohort study. BMJ. 335:1134–1139.
165. Rombaut, R., Camp, J. V., and Dewettinck, K., (2005). Analysis of phospho- and sphingolipids in dairy products by a new HPLC method. J. Dairy Sci. 88:482–488.
166. Saavedra, J. M., Bauman, N. A., Oung, I., Perman, J. A., and Yolken, R. H., (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046–1049.
167. Sadrzadeh-Yeganeh, H., Elmadfa, I., Djazayery, A., Jalali, M., Heshmat, R., and Chamary, M., (2010). The effects of probiotic and conventional yoghurt on lipid profile in women. Br. J. Nutr. 103:1778–1783.
168. Sakamoto, I., Igarashi, M., Kimura, K., Takagi, A., Miwa, T., and Koga, Y., (2001). Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother. 47:709–710.
169. Salzman, N. H., Underwood, M. A., and Bevins, C. L., (2007). Paneth cells, defensins, and the commensal microbiota:A hypothesis on intimate interplay at the intestinal mucosa. Semin. Immunol. 19:70–83.
170. Scaldaferri, F., Pizzoferrato, M., Gerardi, V., Lopetuso, L., and Gasbarrini, A., (2012). The gut barrier:New acquisitions and therapeutic approaches. J. Clin. Gastroenterol. 46:S12–S17.
171. Schaafsma, G., Meuling, W. J. A., Van Dokkum, W., and Bouley, C., (1998). Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur. J. Clin. Nutr. 52:436–440.
172. Scharl, M., Geisel, S., Vavricka, S. R., and Rogler, G., (2010). Dying in yoghurt:The number of living bacteria in probiotic yoghurt decreases under exposure to room temperature. Digestion 83:13–17.
173. Schiffrin, E. J., Brassart, D., Servin, A. L., Rochat, F., and Donnet-Hughes, A., (1997). Immune modulation of blood leukocytes in humans by lactic acid bacteria:Criteria for strain selection. Am. J. Clin. Nutr. 66:515S–520S.
174. Schiffrin, E. J., Parlesak, A., Bode, C., Bode, J. C., van't Hof, M. A., Grathwohl, D., et al. (2009). Probiotic yogurt in the elderly with intestinal bacterial overgrowth:Endotoxaemia and innate immune functions. Br. J. Nutr. 101:961–966.
175. Schillinger, U., (1999). Isolation and identification of lactobacilli from novel-type probiotic and mild yoghurts and their stability during refrigerated storage. Int. J. Food Microbiol. 47:79–87.
176. Schlee, M., Harder, J., Köten, B., Stange, E. F., Wehkamp, J., and Fellermann, K., (2008). Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2. Clin. Exp. Immunol. 151:528–535.
177. Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F., and Fellermann, K., (2007). Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 75:2399–2407.
178. Schmitz, H., Fromm, M., Bentzel, C. J., Scholz, P., Detjen, K., Mankertz, J., et al. (1999). Tumor necrosis factor-alpha (TNFα) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J. Cell Sci. 112:137–146.
179. Shah, N. P., (2007). Functional cultures and health benefits. Int. Dairy J. 17:1262–1277.
180. Shahani, K. M., and Chandan, R. C., (1979). Nutritional and healthful aspects of cultured and culture-containing dairy foods. J. Dairy Sci. 62:1685–1694.
181. Shaw, J. E., Sicree, R. A., and Zimmet, P. Z., (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87:4–14.
182. Sheikh, M. S., Santa Ana, C. A., Nicar, M. J., Schiller, L. R., and Fordtran, J. S., (1987). Gastrointestinal absorption of calcium from milk and calcium salts. N. Engl. J. Med. 317:532–536.
183. Shoelson, S. E., Lee, J., and Goldfine, A. B., (2006). Inflammation and insulin resistance. J. Clin. Invest. 116:1793–1801.
184. Shulman, G. I., (2000). Cellular mechanisms of insulin resistance. J. Clin. Invest. 106:171–176.
185. Sluijs, I., Forouhi, N. G., Beulens, J. W. J., Van Der Schouw, Y. T., Agnoli, C., Arriola, L., et al. (2012). The amount and type of dairy product intake and incident type 2 diabetes:Results from the EPIC-InterAct Study. Am. J. Clin. Nutr. 96:382–390.
186. Smith, T. M., Kolars, J. C., Savaiano, D. A., and Levitt, M. D., (1985). Absorption of calcium from milk and yogurt. Am. J. Clin. Nutr. 42:1197–1200.
187. Soedamah-Muthu, S. S., Verberne, L. D. M., Ding, E. L., Engberink, M. F., and Geleijnse, J. M., (2012). Dairy consumption and incidence of hypertension:A dose-response meta-analysis of prospective cohort studies. Hypertension 60:1131–1137.
188. Solinas, G., and Karin, M., (2010). JNK1 and IKKβ:Molecular links between obesity and metabolic dysfunction. FASEB J. 24:2596–2611.
189. Sommansson, A., Nylander, O., and Sjöblom, M., (2013). Melatonin decreases duodenal epithelial paracellular permeability via a nicotinic receptor-dependent pathway in rats in vivo. J. Pineal Res. 54:282–291.
190. Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., et al. (2009). The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin. Gastroenterol. Hepatol. 7:1202–1209.e1201.
191. Stoll, L. L., Denning, G. M., Li, W. G., Rice, J. B., Harrelson, A. L., Romig, S. A., et al. (2004). Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells:Expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J. Immunol. 173:1336–1343.
192. Stuart, R. O., Sun, A., Panichas, M., Hebert, S. C., Brenner, B. M., and Nigam, S. K., (1994). Critical role for intracellular calcium in tight junction biogenesis. J. Cell Physiol. 159:423–433.
193. Struijk, E. A., Heraclides, A., Witte, D. R., Soedamah-Muthu, S. S., Geleijnse, J. M., Toft, U., et al. (2013). Dairy product intake in relation to glucose regulation indices and risk of type 2 diabetes. Nutr. Metab. Cardiovasc. Dis 23:822–828.
194. Sun, L., Yu, Z., Ye, X., Zou, S., Li, H., Yu, D., et al. (2010). A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33:1925–1932.
195. Teixeira, T. F. S., Souza, N. C. S., Chiarello, P. G., Franceschini, S. C. C., Bressan, J., Ferreira, C. L. L. F., et al. (2012). Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin. Nutr. 31:735–740.
196. Tenenbaum, A., and Fisman, E. Z., (2012). Fibrates are an essential part of modern anti-dyslipidemic arsenal:spotlight on atherogenic dyslipidemia and residual risk reduction. Cardiovasc. Diabetol. 11:125.
197. Thomas, A. P., Dunn, T. N., Drayton, J. B., Oort, P. J., and Adams, S. H., (2012). A high calcium diet containing nonfat dry milk reduces weight gain and associated adipose tissue inflammation in diet-induced obese mice when compared to high calcium alone. Nutr. Metab. (Lond). 9:3.
198. Tilg, H., and Kaser, A., (2011). Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121:2126–2132.
199. Tong, X., Dong, J. Y., Wu, Z. W., Li, W., and Qin, L. Q., (2011). Dairy consumption and risk of type 2 diabetes mellitus:A meta-analysis of cohort studies. Eur. J. Clin. Nutr. 65:1027–1031.
200. Tsuchiya, A., Almiron-Roig, E., Lluch, A., Guyonnet, D., and Drewnowski, A., (2006). Higher satiety ratings following yogurt consumption relative to fruit drink or dairy fruit drink. J. Am. Diet. Assoc. 106:550–557.
201. Tsukita, S., Furuse, M., and Itoh, M., (2001). Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2:285–293.
202. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., and Gordon, J. I., (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–1031.
203. Turner, J. R., (2009). Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9:799–809.
204. Van Bossuyt, H., De Zanger, R. B., and Wisse, E., (1988). Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts. J. Hepatol. 7:325–337.
205. Van Kruijsdijk, R. C. M., Van Der Wall, E., and Visseren, F. L. J., (2009). Obesity and cancer:The role of dysfunctional adipose tissue. Cancer Epidemiol. Biomarkers Prev. 18:2569–2578.
206. Van Meijl, L. E. C., Vrolix, R., and Mensink, R. P., (2008). Dairy product consumption and the metabolic syndrome. Nutr. Res. Rev. 21:148–157.
207. Van Niel, C. W., Feudtner, C., Garrison, M. M., and Christakis, D. A., (2002). Lactobacillus therapy for acute infectious diarrhea in children:A meta-analysis. Pediatrics 109:678–684.
208. Vélez, M. P., Hermans, K., Verhoeven, T. L. A., Lebeer, S. E., Vanderleyden, J., and De Keersmaecker, S. C. J., (2007). Identification and characterization of starter lactic acid bacteria and probiotics from Columbian dairy products. J. Appl. Microbiol. 103:666–674.
209. Wadden, T. A., Webb, V. L., Moran, C. H., and Bailer, B. A., (2012). Lifestyle modification for obesity:New developments in diet, physical activity, and behavior therapy. Circulation 125:1157–1170.
210. Warensjö, E., Jansson, J. H., Cederholm, T., Boman, K., Eliasson, M., Hallmans, G., et al. (2010). Biomarkers of milk fat and the risk of myocardial infarction in men and women:A prospective, matched case-control study. Am. J. Clin. Nutr. 92:194–202.
211. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante Jr, A. W., (2003). Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:1796–1808.
212. Whigham, L. D., Cook, M. E., and Atkinson, R. L., (2000). Conjugated linoleic acid:Implications for human health. Pharmacol. Res. 42:503–510.
213. Woof, J. M., and Ken, M. A., (2006). The function of immunoglobulin A in immunity. J. Pathol. 208:270–282.
214. Wu, H., Ghosh, S., Perrard, X. D., Feng, L., Garcia, G. E., Perrard, J. L., et al. (2007). T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115:1029–1038.
215. Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., et al. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112:1821–1830.
216. Yang, H., Kiristioglu, I., Fan, Y., Forbush, B., Bishop, D. K., Antony, P. A., et al. (2002). Interferon-gamma expression by intraepithelial lymphocytes results in a loss of epithelial barrier function in a mouse model of total parenteral nutrition. Ann. Surg. 236:226–234.
217. Yang, R., Han, X., Uchiyama, T., Watkins, S. K., Yaguchi, A., Delude, R. L., et al. (2003). IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 285:G621–G629.
218. Yang, Y. J., and Sheu, B. S., (2012). Probiotics-containing yogurts suppress helicobacter pylori load and modify immune response and intestinal microbiota in the helicobacter pylori-infected children. Helicobacter 17:297–304.
219. Youakim, A., and Ahdieh, M., (1999). Interferon-γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am. J. Physiol. Gastrointest. Liver Physiol. 276:G1279–G1288.
220. Zasloff, M., (2002). Antimicrobial peptides of multicellular organisms. Nature 415:389–395.
221. Zemel, M. B., Shi, H., Greer, B., Dirienzo, D., and Zemel, P. C., (2000). Regulation of adiposity by dietary calcium. FASEB J. 14:1132–1138.
222. Zemel, M. B., Thompson, W., Milstead, A., Morris, K., and Campbell, P., (2004). Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes. Res. 12:582–590.
223. Zhao, Y., Martin, B. R., and Weaver, C. M., (2005). Calcium bioavailability of calcium carbonate fortified soymilk is equivalent to cow's milk in young women. J. Nutr. 135:2379–2382.
224. Zsivkovits, M., Fekadu, K., Sontag, G., Nabinger, U., Huber, W. W., Kundi, M., et al. (2003). Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains. Carcinogenesis 24:1913–1918.